With extensive experience in Chapter 11 and out-of-court restructurings, Jim Wilton has represented debtors, creditors’ committees, corporate directors and officers, and acquirers of distressed assets in major cases throughout the United States. Jim’s clients include major pharmaceutical companies, biotech companies, strategic purchasers of assets, and boards of directors of troubled companies.
Experience
Representations in 363 SalesGenocea Biosciences, a public company, through its sale of assets, including significant clinical intellectual property assets, and wind-down through a chapter 11 proceeding.
Amgen, Inc. in acquisition of assets of Unilife Corporation, a manufacturer of medical devices.
Champion Home Builders in Chapter 7 acquisition of assets of Innovative Building Systems, LLC.<p
</p
Oscient Pharmaceutical Corporation in Chapter 11 sales of two commercial stage products, including litigation with patent licensors and secured lender.
Simmons Bedding Co. in Chapter 11 bid to acquire manufacturing plants of sole source supplier, Western Nonwovens, Inc.
Major pharmaceutical company in Chapter 11 acquisition of dengue fever vaccine in Phase 2 clinical trials in Chapter 11 case of Hawaii Biotech, Inc. Representations in Other Matters Chapter 11 debtor in U.S. Supreme Court case, Mission Products Holdings, Inc. v. Tempnology, LLC, to determine rights of trademark licensee following rejection of license.
An Ivy League university's endowment in connection with investments in chapter 11 case of Global Maritime Investment.
Holley Performance Products, Inc., manufacturer of high performance parts for the automotive aftermarket in prepackaged Chapter 11 reorganization.
Private equity fund in acquisition of USinternetworking, Inc. through pre-negotiated Chapter 11 plan of reorganization.
National fitness equipment manufacturer in exchange offer for $100 million of public debt, utilizing a prepackaged reorganized plan as an alternative to induce bondholders to participate in exchange.
Major pharmaceutical company in out-of-court workout of more than $100 million of debt owed by specialty pharmaceutical company and sole source supplier.
Served as bankruptcy court appointed mediator in connection with objections of twelve creditors holding $150 million of secured debt in Chapter 11 reorganization of Cashman Equiment Corporation, a supplier to the maritime construction and oil and gas industries.